Induction of immune tolerance by neonatal intravenous injection of human factor VIII in murine hemophilia A

This publication has 40 references indexed in Scilit:

• Neonatal Exposure to Antigen Induces a Defective CD40 Ligand Expression that Undermines Both IL-12 Production by APC and IL-2 Receptor Up-Regulation on Splenic T Cells and Perpetuates IFN-γ-Dependent T Cell Anergy
  The Journal of Immunology, 2001
• Safety and efficacy of a new recombinant FVIII formulated with sucrose (rFVIII-FS) in patients with haemophilia A: a long-term, multicentre clinical study in Japan
  Haemophilia, 2001
• Incidence of inhibitors in haemophilia A patients – a review of recent studies of recombinant and plasma‐derived factor VIII concentrates
  Haemophilia, 1999
• Neonatal Exposure to a Self-Peptide–Immunoglobulin Chimera Circumvents the Use of Adjuvant and Confers Resistance to Autoimmune Disease by a Novel Mechanism Involving Interleukin 4 Lymph Node Deviation and Interferon γ–mediated Splenic Anergy
  The Journal of Experimental Medicine, 1998
• The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-alpha beta-transgenic model.
  The Journal of Experimental Medicine, 1995
• Targeted disruption of the mouse factor VIII gene produces a model of haemophilia A
  Nature Genetics, 1995
• Hemophilia A
  New England Journal of Medicine, 1994
• Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs
  The Lancet, 1992
• Regulation of antibody isotype secretion by subsets of antigen-specific helper T cells
  Nature, 1988
• Cellular Mechanisms of Immunologic Tolerance
  Annual Review of Immunology, 1983